Journals / Turkish Journal of Urology / 2019 / Cilt: 45 - Sayı: 1

The evaluation of the effectiveness of Gilaburu (Viburnum opulus L.) extract in the medical expulsive treatment of distal ureteral stones

Pages
63–69
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Prospective, randomized studies are needed to support these results.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Medical expulsive therapy is an important non-invasive treatment modality that facilitates thepassage of ureteral stones.
📊
Key Findings & Data:The aim of the present study was to evaluate the efficacy of Gilaburu (Viburnumopulus) extract in the treatment of distal ureteral stones <10 mm.Material and methods: Data of 103 patients were retrospectively analyzed.
💡
Conclusion & Impact:Prospective, randomized studies are needed to support these results.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: Medical expulsive therapy is an important non-invasive treatment modality that facilitates thepassage of ureteral stones. The aim of the present study was to evaluate the efficacy of Gilaburu (Viburnumopulus) extract in the treatment of distal ureteral stones <10 mm.Material and methods: Data of 103 patients were retrospectively analyzed. Patients were divided into twogroups: those given V. opulus 1000 mg peroral 3×2 and diclofenac 50 mg peroral on-demand (n=53) andthose given only diclofenac sodium 50 mg peroral on-demand (n=50). Comparisons of stone expulsion ratesand the elapsed time until the expulsion between the groups were determined as primary outcome measures.The comparison of the need for additional treatment [ureteroscopy (URS) or extracorporeal shock wavelithotripsy (ESWL)], the need for emergency admission, analgesic requirement, and the complication ratesin additional treatment were determined as secondary outcome measures.Results: The mean age of the patients was 45.8±14.5 years. The rate of stone expulsion was significantlyhigher (82% vs. 66%, p=0.026), and elapsed time to stone expulsion was significantly shorter (9±1.8 vs.14±2.3 day, p=0.018) in the V. opulus group. The need for additional treatment (URS and ESWL) and analgesic requirement was less in the V. opulus group (9.4% vs. 20%, p=0.038 and 24.5% vs. 44%, p=0.042,respectively).Conclusion: V. opulus is an herbal treatment alternative that facilitates the passage of ureteral stones <10mm. Prospective, randomized studies are needed to support these results.

🔖

Cite This Article

KIZILAY, F., ÜLKER, V., ÇELİK, O., ÖZDEMİR, T., ÇAKMAK, Ö., CAN, E., NAZLI, O. (2019). The evaluation of the effectiveness of Gilaburu (Viburnum opulus L.) extract in the medical expulsive treatment of distal ureteral stones. Turkish Journal of Urology, Cilt: 45 - Sayı: 1, 63–69. https://ajindex.com/articles/379805

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Manglaviti G, Tresoldi S, Guerrer CS, Di Leo G, Montanari E, Sardanelli F, et al. In vivo evaluation of the chemical composition of urinary stones using dual-energy CT. AJR Am J Roentgenol 2011
  2. W76-83. [CrossRef] 2. Ahmed AF, Al-Sayed AY. Tamsulosin versus Alfuzosin in the Treatment of Patients with Distal Ureteral Stones: Prospective, Randomized, Comparative Study. Korean J Urol 2010
  3. [CrossRef] 3. Sidhu R, Bhatt S, Dogra VS. Renal colic. Ultrasound Clinics 2008
  4. [CrossRef] 4. Coll DM, Varanelli MJ, Smith RC. Relationship of spontaneous passage of ureteral calculi to stone size and location as revealed by unenhanced helical CT. AJR Am J Roentgenol 2002
  5. [CrossRef] 5. Preminger GM, Tiselius HG, Assimos DG, Alken P, Buck C, Gallucci M, et al. 2007 guideline for the management of ureteral calculi. J Urol 2007
  6. [CrossRef] 6. Campschroer T, Zhu Y, Duijvesz D, Grobbee DE, Lock M. Alpha‐blockers as medical expulsive therapy for ureteral stones. The Cochrane Library 2014. [CrossRef] 7. Dauw CA, Kaufman SR, Hollenbeck BK, Roberts WW, Faerber GJ, Wolf JS Jr, et al. Expulsive therapy versus early endoscopic stone removal in patients with acute renal colic: a comparison of indirect costs. J Urol 2014
  7. [CrossRef] 8. Turk C, Knoll T, Seitz C, Skolarikos A, Chapple C, McClinton S, et al. Medical Expulsive Therapy for Ureterolithiasis: The EAU Recommendations in 2016. Eur Urol 2017
  8. [CrossRef] 9. Pearle MS, Goldfarb DS, Assimos DG, Curhan G, Denu-Ciocca CJ, Matlaga BR, et al. Medical management of kidney stones: AUA guideline. J Urol 2014
  9. [CrossRef] 10. Gratzke C, Uckert S, Reich O, Schlenker B, Tilki D, Seitz M, et al. PDE5 inhibitors. A new option in the treatment of ureteral colic?. Urologe A 2007
  10. [CrossRef] 11. Malin JM, Jr., Deane RF, Boyarsky S. Characterisation of adrenergic receptors in human ureter. Br J Urol 1970
  11. Elgalaly H, Sakr A, Fawzi A, Salem EA, Desoky E, Shahin A, et al. Silodosin vs tamsulosin in the management of distal ureteric stones: A prospective randomised study. Arab J Urol 2016
  12. [CrossRef] 13. Bai Y, Yang Y, Wang X, Tang Y, Han P, Wang J. Tadalafil Facilitates the Distal Ureteral Stone Expulsion: A Meta-Analysis. J Endourol 2017
  13. [CrossRef] 14. Seitz C, Liatsikos E, Porpiglia F, Tiselius HG, Zwergel U. Medical therapy to facilitate the passage of stones: what is the evidence? Eur Urol 2009
  14. [CrossRef] 15. Becker AJ,